Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oxford Biomedica PLC Share Issue/Capital Change 2023

Jan 3, 2023

5190_sha_2023-01-03_cd84be4e-5412-4ef7-9f27-c8d5f249c2a3.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5695L

Oxford Biomedica PLC

03 January 2023

Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Employee Share Option Scheme
Period of return: From: 1 July 2022 To: 31 December 2022
Balance of unallotted securities under scheme(s) from previous return: 336,239
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 4,665
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 331,574
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Long Term Incentive Plan
Period of return: From: 1 July 2022 To: 31 December 2022
Balance of unallotted securities under scheme(s) from previous return: 519,668
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 180,349
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 339,319
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Deferred Bonus Plan
Period of return: From: 1 July 2022 To: 31 December 2022
Balance of unallotted securities under scheme(s) from previous return: 206,835
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 4,390
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 202,445
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: Sharesave Scheme
Period of return: From: 1 July 2022 To: 31 December 2022
Balance of unallotted securities under scheme(s) from previous return: 331,484
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): NIL
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 331,484

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRBJMRTMTBMBPJ